Genta Incorporated: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	48
ISBN Number	not applicable
Product Code	DAT09437

Price

£265.00
approximately: $468 | €336

PRINT £265 ($468 | €336)

Order above formats by FAX

Summary

Introduction

Genta, a clinical development stage biopharmaceutical company, aims to build on its core competitive strength of oncology development expertise in providing biopharmaceutical products for the treatment of cancer and to expand the pipeline of products in two therapeutic categories, DNA/RNA Medicines and Small Molecules, through internal development, licensing and acquisitions.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Genta, a biopharmaceutical company, is engaged in the identification, development, and commercialization of drugs for the treatment of cancer and related diseases in the US. The company's research portfolio consists of two programs, DNA/RNA Medicines and Small Molecules.

Genta's total revenues decreased at a CAGR of 33% during 2002-2006, from $4 million in 2002 to $1 million in 2006. The company's biggest contributor to revenue during 2002-2006 was development funding under the agreement with Aventis.

Unless Genasense receives approval, the company's only revenue source out to 2010 will be Ganite sales. Revenues from Ganite sales are expected to decrease at a CAGR of 9%, from $0.7 million in 2006 to $0.5 million in 2010, which is attributable to reduced spending and focus on the development, sale and marketing of Ganite by the company.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Genta - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Genta - Key Strategic Revenues, 2002-2006 ($ Mn)
- Table 1: Genta - Key Facts
- Table 2: Genta - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Genta - Key Events Impacting Share Price Performance
- Table 4: Genta - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Genta - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 6: Genta - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Genta - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Genta - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 9: Genta - Marketed Products
- Table 10: Genta - in-house Pipeline Products
- Table 11: Genta - Collaboration Products
- Table 12: Genta - Historical Product Sales, 2002-2006 ($ Mn)
- Table 13: Genta - Forecast Sales, 2006-2010 ($ Mn)
- Table 14: Genta - Key Suppliers
- Table 15: Genta - Key Shareholders
- Table 16: Genta - SWOT Analysis Summary
- Table 17: Genta - Value Chain Analysis
- Table 18: Genta - Scorecard
- Table 19: Genta - Key Employees
- Table 20: Genta - Financial and Operational Overview